Prairie Pharms Overview
- Founded
- 2010
- Status
- Private
- Latest Deal Type
- Angel
- (Cancelled)
- Latest Deal Amount
- $12M
Prairie Pharms General Information
Description
Developer of small molecule plant extracts that contains Thymoquinone. The company's product used to create pharmaceutical grade, lipid soluble and cell permeable human health products.
Contact Information
Website
Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Commercial Products
Primary Office
- 3261 Cameo Avenue
- Nora Springs, IA 50458
- United States
+1 (641) 000-0000
Prairie Pharms Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Angel (individual) | 14-Apr-2016 | $12M | Cancelled | Generating Revenue | ||
| 1. Angel (individual) | 29-May-2013 | 00000 | 00000 | Completed | Startup |
Prairie Pharms Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| William Rohlfsen | Manager & Board Member |
Prairie Pharms Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| John Relher | Prairie Pharms | Board Member | 000 0000 |
| Joseph Saluri | Prairie Pharms | Board Member | 000 0000 |
| Nicholas Rohlfsen | Prairie Pharms | Board Member | 000 0000 |
| William Rohlfsen | Prairie Pharms | Manager & Board Member | 000 0000 |